Edition:
United Kingdom

Allogene Therapeutics Inc (ALLO.OQ)

ALLO.OQ on NASDAQ Stock Exchange Global Select Market

29.19USD
7:54pm BST
Change (% chg)

$0.08 (+0.26%)
Prev Close
$29.12
Open
$29.10
Day's High
$29.62
Day's Low
$28.76
Volume
65,469
Avg. Vol
119,536
52-wk High
$35.55
52-wk Low
$21.67

About

Allogene Therapeutics, Inc. is a clinical stage immuno-oncology company. The Company is focused on developing and commercializing of allogeneic T cell therapies for the treatment of cancer. It is involved in developing a pipeline of multiple allogeneic chimeric antigen receptor (CAR) T cell product candidates utilizing protein... (more)

Overall

No Ratios Available.

Financials

  ALLO.OQ Industry Sector
P/E (TTM): -- 69.30 32.55
EPS (TTM): -- -- --
ROI: -- 8.91 13.82
ROE: -- 10.05 15.24

Earnings vs. Estimates